Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,710Revenue $M4.8Net Margin (%)-3,587.7Z-Score-2.2
Enterprise Value $M3,113EPS $-1.7Operating Margin %-3,549.0F-Score1
P/E(ttm))0Cash Flow Per Share $-1.3Pre-tax Margin (%)-3,587.7Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %-21.7Quick Ratio7.1Cash flow > EarningsY
Price/Sales7855-y EBITDA Growth Rate %-21.1Current Ratio7.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-25.1Higher Current Ratio y-yN
Dividend Yield %1.1Insider Buy (3m)1ROE % (ttm)-57.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M113ROI % (ttm)-32.8Gross Margin Increase y-yN

Gurus Latest Trades with THRX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THRXRichard Perry 2014-06-30 Buy 1.2%$21.154 - $30.1
($23.88)
$ 23.56-1%New holding, 1517208 sh.1,517,208
THRXSeth Klarman 2014-06-30 Reduce-0.23%$21.154 - $30.1
($23.88)
$ 23.56-1%Reduce -1.5%20,395,056
THRXSeth Klarman 2014-03-31 Add0.42%$24.31 - $32.63
($29.32)
$ 23.56-20%Add 2.79%20,705,801
THRXSeth Klarman 2013-12-31 Add1.65%$27.19 - $32.81
($29.19)
$ 23.56-19%Add 8.83%20,144,301
THRXJean-Marie Eveillard 2013-12-31 Add0.03%$27.19 - $32.81
($29.19)
$ 23.56-19%Add 23.4%1,509,404
THRXSeth Klarman 2013-09-30 Add2.3%$28.86 - $34.36
($31.06)
$ 23.56-24%Add 11.92%18,510,371
THRXSeth Klarman 2013-06-30 Add2.85%$18.15 - $33.74
($26.83)
$ 23.56-12%Add 22.02%16,538,977
THRXJean-Marie Eveillard 2013-06-30 Add0.08%$18.15 - $33.74
($26.83)
$ 23.56-12%Add 139.14%1,109,620
THRXJean-Marie Eveillard 2012-06-30 Add0.01%$14.11 - $19.04
($16.72)
$ 23.5641%Add 24.23%509,710
THRXSeth Klarman 2012-03-31 Add0.22%$13.21 - $16.28
($13.91)
$ 23.5669%Add 2.3%14,553,800
THRXJean-Marie Eveillard 2012-03-31 Add0.01%$13.21 - $16.28
($13.91)
$ 23.5669%Add 25.59%410,310
THRXSeth Klarman 2011-09-30 Add0.84%$14.05 - $20.04
($16.74)
$ 23.5641%Add 9.76%14,225,961
THRXJulian Robertson 2011-09-30 Sold Out -1.2512%$14.05 - $20.04
($16.74)
$ 23.5641%Sold Out0
THRXJohn Griffin 2011-06-30 Sold Out $17.07 - $23.13
($20)
$ 23.5618%Sold Out0
THRXJean-Marie Eveillard 2011-06-30 Reduce-0.02%$17.07 - $23.13
($20)
$ 23.5618%Reduce -33.79%326,710
THRXJean-Marie Eveillard 2011-03-31 Add0.02%$16.91 - $20.77
($18.79)
$ 23.5625%Add 51.02%493,410
THRXWilbur Ross 2011-03-31 Sold Out $16.91 - $20.77
($18.79)
$ 23.5625%Sold Out0
THRXJulian Robertson 2011-03-31 Reduce-0.35%$16.91 - $20.77
($18.79)
$ 23.5625%Reduce -20.94%211,686
THRXWilbur Ross 2010-12-31 Buy 0.13%$16.12 - $23.08
($18.83)
$ 23.5625%New holding, 45219 sh.45,219
THRXJulian Robertson 2010-09-30 Buy 1.94%$9.53 - $16
($11.92)
$ 23.5698%New holding, 287763 sh.287,763
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
THRX Richard Perry 2014-06-301,517,2081.351.2New Buy
THRX Jean-Marie Eveillard 2014-06-301,595,5201.420.12
THRX Seth Klarman 2014-06-3020,395,05618.119.9-1.5%
Premium Most recent portfolio changes are included for Premium Members only!


THRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEE JUNNINGSr. VP, Technical Operations 2014-08-13Sell53,424$22.54.71view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-08-12Sell28,156$22.136.46view
GLAXOSMITHKLINE PLC10% Owner 2014-08-11Buy172,651$3912270-100view
GLAXOSMITHKLINE PLC10% Owner 2014-05-09Buy317,770$8544840-100view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-03-03Sell65,806$36.73-35.86view
Mammen MathaiSVP, Research & Early Clin Dev 2014-02-14Sell35,000$39.36-40.14view
GLAXOSMITHKLINE PLC10% Owner 2014-02-11Buy342,229$12850700-100view
GLAXOSMITHKLINE PLC10% Owner 2013-10-29Buy130,473$4913610-100view
Winningham Rick ECEO 2013-09-12Sell22,353$40.03-41.14view
Mammen MathaiSVP, Research & Early Clin Dev 2013-07-30Sell7,000$36.51-35.47view

Press Releases about THRX :

    Quarterly/Annual Reports about THRX:

    News about THRX:

    Articles On GuruFocus.com
    Seth Klarman Buys Cheniere Energy, Keryx Biopharmaceuticals, Idenix Pharmaceuticals, Sells BP, Fidel May 15 2014 
    Seth Klarman Buys Micron Technology, Theravance, PBF Energy, Sells BP, AIG, Yamana Gold Nov 13 2013 
    Seth Klarman's Top 5 Second Quarter Holdings Aug 14 2013 
    Top Four from Baupost’s Seth Klarman Jul 18 2013 
    What Can We Earn If We Invest in the Top Five Holdings of the Baupost Group? May 29 2013 
    Weekly CEO Sells Highlight: Texas Roadhouse Inc., Theravance Inc., AmerisourceBergen Corp. and Nuanc May 06 2013 
    WEEKLY CFO SELLS HIGHLIGHT: THRX, BERY, IPG, PG, ZNGA, TSS May 05 2013 
    Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN Jan 07 2013 
    Weekly CFO Sells Highlight: CMCSA, ACTU, FRGI, PETM, THRX, DXPE, CRZO Jun 04 2012 
    sk adding May 12 2012 

    More From Other Websites
    Strong On High Relative Volume: Theravance (THRX) Aug 26 2014
    Why the Baupost Group starts new position in Theravance Biopharma Aug 25 2014
    THERAVANCE INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 22 2014
    Theravance to Present at the Baird 2014 Health Care Conference Aug 21 2014
    THERAVANCE INC Financials Aug 15 2014
    Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2 Aug 08 2014
    THERAVANCE INC Files SEC form 10-Q, Quarterly Report Aug 07 2014
    THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2014
    Theravance Reports Second Quarter 2014 Financial Results Aug 06 2014
    Theravance, Inc. Appoints Michael W. Aguiar as President and Chief Executive Officer Aug 06 2014
    Q2 2014 THERAVANCE INC Earnings Release - After Market Close Aug 06 2014
    Theravance to Report Second Quarter 2014 Financial Results on August 6, 2014 Jul 29 2014
    [$$] At Theravance, It's Hard to Breathe Easy Jul 25 2014
    Theravance (THRX) Is in Oversold Territory: What's Next? Jul 25 2014
    Theravance downgraded at BofA/Merrill Jul 24 2014
    Why A Short Covering Rally Might Come for Theravance (THRX) Stock Jul 22 2014
    UPDATE: Morgan Stanley Reiterates On Theravance As Slow Trends Weigh On Value Jul 21 2014
    Theravance/Glaxo Commence Global Late stage Study on COPD Jul 16 2014
    THERAVANCE INC Files SEC form 8-K, Other Events Jul 16 2014
    GSK and Theravance Announce Initiation of Phase III Programme With Fixed Dose Triple Combination... Jul 16 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK